Unraveling Pathophysiological Mechanisms of Parkinson’s Disease: Contribution of CSF Biomarkers
Biomarker Insights · 2020-01 · 15 · 117727192096407
DOI: 10.1177/1177271920964077 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomarker Insights, online erschienen am 12.10.2020. Verfasst von Lucia Farotti und 3 weiteren Autor:innen. Beteiligte Einrichtung: Section of Neurology, Department of Medicine, University of Perugia, Perugia, Italy. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 111 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Diagnosis of Parkinson’s disease (PD) relies on clinical history and physical examination, but misdiagnosis is common in early stages. Identification of biomarkers for PD may allow for early and more precise diagnosis and provide information about prognosis. Developments in analytical chemistry allow for the detection of a large number of molecules in cerebrospinal fluid (CSF), which are known to be associated with the pathogenesis of PD. Given the pathophysiology of PD, CSF α-synuclein species have the strongest rationale for use, also providing encouraging preliminary results in terms of early diagnosis. In the field of classical Alzheimer’s disease (AD) biomarkers, low CSF Aβ 42 levels have shown a robust prognostic value in terms of development of cognitive impairment. Other CSF biomarkers including lysosomal enzymes, neurofilament light chain, markers of neuroinflammation and oxidative stress, although promising, have not proved to be reliable for diagnostic and prognostic purposes yet. Overall, the implementation of CSF biomarkers may give a substantial contribution to the optimal use of disease-modifying drugs.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Section of Neurology, Department of Medicine, University of Perugia, Perugia, Italy.
Zitieren
APA
Farotti, L., Paolini Paoletti, F., Simoni, S., & Parnetti, L. (2020). Unraveling Pathophysiological Mechanisms of Parkinson’s Disease: Contribution of CSF Biomarkers. Biomarker Insights, 15, 117727192096407. https://doi.org/10.1177/1177271920964077
Vancouver
Farotti L, Paolini Paoletti F, Simoni S, Parnetti L. Unraveling Pathophysiological Mechanisms of Parkinson’s Disease: Contribution of CSF Biomarkers. Biomarker Insights. 2020;15:117727192096407. doi:10.1177/1177271920964077
BibTeX
@article{Farotti2020,
author = {Farotti, Lucia and Paolini Paoletti, Federico and Simoni, Simone and Parnetti, Lucilla},
title = {Unraveling Pathophysiological Mechanisms of Parkinson’s Disease: Contribution of CSF Biomarkers},
journal = {Biomarker Insights},
year = {2020},
volume = {15},
pages = {117727192096407},
doi = {10.1177/1177271920964077}
}
EUVIMED